Literature DB >> 18574845

Central bisectionectomy for centrally located hepatocellular carcinoma.

J G Lee1, S B Choi, K S Kim, J S Choi, W J Lee, B R Kim.   

Abstract

BACKGROUND: Central bisectionectomy, which involves the removal of the central hepatic segments (IVA, IVB, V, VIII) for hepatocellular carcinoma (HCC), is performed to reduce the volume of resected liver and to overcome the problem of insufficient future residual volume.
METHODS: Twenty-seven patients with HCC underwent central bisectionectomy from January 1998 to April 2007 in one hospital. The surgical techniques, clinicopathological characteristics and outcomes were reviewed.
RESULTS: The median operating time was 330 min. Twelve patients developed postoperative complications and two died. The most common complication, occurring in five patients, was bile duct injury leading to biloma or bile leakage. Median follow-up was 19.1 (range 1.4-102.2) months and eight patients developed a recurrence. Twenty-four patients were alive at the time of writing.
CONCLUSION: Although biliary complications occur somewhat frequently, central bisectionectomy in centrally located HCC can be performed safely to preserve liver volume. (c) 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18574845     DOI: 10.1002/bjs.6130

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  Outcomes of central bisectionectomy for hepatocellular carcinoma.

Authors:  Thomas K Gallagher; Albert C Y Chan; Ronnie T P Poon; Tan To Cheung; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-11-21       Impact factor: 3.647

2.  Impact of Glissonean pedicle approach for centrally located hepatocellular carcinoma in mongolia.

Authors:  Jigjidsuren Chinburen; Michele Gillet; Masakazu Yamamoto; Tsiiregzen Enkh-Amgalan; Erdenebileg Taivanbaatar; Chinbold Enkhbold; Puntsagdulam Natsagnyam
Journal:  Int Surg       Date:  2015-02

3.  Percutaneous radiofrequency ablation versus partial hepatectomy for small centrally located hepatocellular carcinoma.

Authors:  Wei-Xing Guo; Ju-Xian Sun; Yu-Qiang Cheng; Jie Shi; Nan Li; Jie Xue; Meng-Chao Wu; Yi Chen; Shu-Qun Cheng
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

4.  Central hepatectomy for centrally located malignant liver tumors: A systematic review.

Authors:  Ser Yee Lee
Journal:  World J Hepatol       Date:  2014-05-27

5.  Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison.

Authors:  Ser Yee Lee; Eran Sadot; Joanne F Chou; Mithat Gönen; Thomas Peter Kingham; Peter J Allen; Ronald P DeMatteo; William R Jarnagin; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2015-09-10       Impact factor: 3.647

6.  Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: a pilot study.

Authors:  Fei Tian; Jian-Xiong Wu; Wei-Qi Rong; Li-Ming Wang; Fan Wu; Wei-Bo Yu; Song-Lin An; Fa-Qiang Liu; Li Feng; Chao Bi; Yun-He Liu
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

7.  R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma.

Authors:  Weibo Yu; Weiqi Rong; Liming Wang; Fan Wu; Quan Xu; Jianxiong Wu
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

8.  Mesohepatectomy Versus Extended Hemihepatectomies for Centrally Located Liver Tumors: A Meta-Analysis.

Authors:  Jianbo Li; Chengdi Wang; Jiulin Song; Nan Chen; Li Jiang; Jiayin Yang; Lunan Yan
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 9.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

10.  Mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma.

Authors:  Hiromichi Ishii; Shinpei Ogino; Koki Ikemoto; Atsushi Toma; Kenji Nakamura; Tsuyoshi Itoh; Toshiya Ochiai
Journal:  World J Surg Oncol       Date:  2013-04-04       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.